ATE145916T1 - Stereoselektives verfahren zur herstellung von beta-anomer angereicherten 2-deoxy-2,2-difluoro-d-ribofuranosyl-3,5-hydrox -geschützten 1-alkyl und aryl-sulfonat-zwischenprodukten - Google Patents

Stereoselektives verfahren zur herstellung von beta-anomer angereicherten 2-deoxy-2,2-difluoro-d-ribofuranosyl-3,5-hydrox -geschützten 1-alkyl und aryl-sulfonat-zwischenprodukten

Info

Publication number
ATE145916T1
ATE145916T1 AT94306253T AT94306253T ATE145916T1 AT E145916 T1 ATE145916 T1 AT E145916T1 AT 94306253 T AT94306253 T AT 94306253T AT 94306253 T AT94306253 T AT 94306253T AT E145916 T1 ATE145916 T1 AT E145916T1
Authority
AT
Austria
Prior art keywords
ribofuranosyl
deoxy
difluoro
alkyl
aryl sulfonate
Prior art date
Application number
AT94306253T
Other languages
English (en)
Inventor
Charles David Jones
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE145916T1 publication Critical patent/ATE145916T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT94306253T 1993-08-25 1994-08-24 Stereoselektives verfahren zur herstellung von beta-anomer angereicherten 2-deoxy-2,2-difluoro-d-ribofuranosyl-3,5-hydrox -geschützten 1-alkyl und aryl-sulfonat-zwischenprodukten ATE145916T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/111,578 US5424416A (en) 1993-08-25 1993-08-25 Process for preparation of 2-deoxy-2,2-difluoro-D-ribofuranosyl-3,5-hydroxy protected-1-alkyl and aryl sulfonates and their use in preparation of 2',2'-difluoro-2'-deoxy nucleosides

Publications (1)

Publication Number Publication Date
ATE145916T1 true ATE145916T1 (de) 1996-12-15

Family

ID=22339311

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94306253T ATE145916T1 (de) 1993-08-25 1994-08-24 Stereoselektives verfahren zur herstellung von beta-anomer angereicherten 2-deoxy-2,2-difluoro-d-ribofuranosyl-3,5-hydrox -geschützten 1-alkyl und aryl-sulfonat-zwischenprodukten

Country Status (9)

Country Link
US (1) US5424416A (de)
EP (1) EP0640614B1 (de)
JP (1) JP3659989B2 (de)
AT (1) ATE145916T1 (de)
CA (1) CA2130618C (de)
DE (1) DE69401045T2 (de)
DK (1) DK0640614T3 (de)
ES (1) ES2094623T3 (de)
GR (1) GR3022477T3 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521294A (en) * 1995-01-18 1996-05-28 Eli Lilly And Company 2,2-difluoro-3-carbamoyl ribose sulfonate compounds and process for the preparation of beta nucleosides
WO1999043691A1 (en) * 1998-02-25 1999-09-02 Emory University 2'-fluoronucleosides
EP1478322A4 (de) 2001-06-22 2007-08-08 Pharmasset Ltd Beta-2'-OR 3'-HALONUCLEOSIDE
US6884880B2 (en) * 2002-08-21 2005-04-26 Ash Stevens, Inc. Process for the preparation of 9-β-anomeric nucleoside analogs
US7214791B2 (en) * 2004-07-01 2007-05-08 Shenzhen Hande Technology Co., Ltd. Method for preparation of 2′-deoxy-2′, 2′-difluoro-β-cytidine or pharmaceutically acceptable salts thereof by using 1,6-anhydro-β-d-glucose as raw material
CN101076536A (zh) * 2004-07-30 2007-11-21 药华医药股份有限公司 β－核苷的立体选择性合成
WO2006119347A1 (en) * 2005-05-02 2006-11-09 Pharmaessentia Corp. STEREOSELECTIVE SYNTHESIS OF β-NUCLEOSIDES
US8895531B2 (en) * 2006-03-23 2014-11-25 Rfs Pharma Llc 2′-fluoronucleoside phosphonates as antiviral agents
KR20100102107A (ko) * 2007-11-06 2010-09-20 파마이센시아 코퍼레이션 β-뉴클레오시드의 새로운 합성 방법
US20090274686A1 (en) * 2008-05-02 2009-11-05 Yat Sun Or Nucleoside phosphonate derivatives

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3282921A (en) * 1964-06-04 1966-11-01 Syntex Corp Halo-deoxynucleosides and processes for the preparation thereof
DE2628202A1 (de) * 1976-06-23 1977-12-29 Max Planck Gesellschaft Verfahren zur herstellung von 2'-substituierten-d-ribofuranosylpurinderivaten
US4211773A (en) * 1978-10-02 1980-07-08 Sloan Kettering Institute For Cancer Research 5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
FR2531962B1 (fr) * 1982-08-17 1986-11-14 Sandoz Sa Nouveaux derives de la desoxyuridine, leur preparation et leur utilisation comme medicaments
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
US4625020A (en) * 1983-11-18 1986-11-25 Bristol-Myers Company Nucleoside process
EP0184365B1 (de) * 1984-12-04 1993-08-04 Eli Lilly And Company Tumorbehandlung bei Säugetieren
CA1295998C (en) * 1985-07-29 1992-02-18 Sai P. Sunkara Nucleosides and their use as antineoplastic agents
US4751221A (en) * 1985-10-18 1988-06-14 Sloan-Kettering Institute For Cancer Research 2-fluoro-arabinofuranosyl purine nucleosides
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
EP0339161A1 (de) * 1988-04-01 1989-11-02 Merrell Dow Pharmaceuticals Inc. Derivate von Fluorphosphonat-Nukleotiden
JPH0232093A (ja) * 1988-06-08 1990-02-01 Merrell Dow Pharmaceut Inc 抗レトロウィルスジフルオロ化ヌクレオシド類
HU906976D0 (en) * 1989-11-13 1991-05-28 Bristol Myers Squibb Co Process for producing 2', 3'-didesoxy-2'-fluoarabinonucleoside analogues
US5256798A (en) * 1992-06-22 1993-10-26 Eli Lilly And Company Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates
US5401861A (en) * 1992-06-22 1995-03-28 Eli Lilly And Company Low temperature process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates
UA41261C2 (uk) * 1992-06-22 2001-09-17 Елі Ліллі Енд Компані Спосіб одержання збагачених бета-аномером нуклеозидів

Also Published As

Publication number Publication date
DE69401045D1 (de) 1997-01-16
CA2130618C (en) 2006-02-14
GR3022477T3 (en) 1997-05-31
EP0640614A2 (de) 1995-03-01
JPH07165782A (ja) 1995-06-27
EP0640614B1 (de) 1996-12-04
DE69401045T2 (de) 1997-04-10
US5424416A (en) 1995-06-13
JP3659989B2 (ja) 2005-06-15
CA2130618A1 (en) 1995-02-26
EP0640614A3 (de) 1995-05-03
ES2094623T3 (es) 1997-01-16
DK0640614T3 (da) 1997-04-14

Similar Documents

Publication Publication Date Title
DE3580803D1 (de) Neue zwischenprodukte und verfahren zur herstellung von 3-acylamino-1-hydroxy-2-azetidinonen.
DE3789746D1 (de) Verfahren zur Herstellung von Zink-Nickel-Phosphatüberzügen.
DE68904940D1 (de) Verfahren und herstellung von adamantan-1-derivaten.
ATE161264T1 (de) Tieftemperatur-verfahren zur herstellung von mit alpha-anomeren angereicherten 2-deoxy-2,2-difluor-d-ribofuranosyl-sulfonaten
DE69311000D1 (de) Verfahren zur Herstellung von mit Alpha-Anomeren angereicherten 1-Halogen-2-Deoxy-2,2-Difluor-D-Ribofuranosyl-Derivaten
DE3882242D1 (de) Fermentationsverfahren zur herstellung von 2-keto-l-gulonsaeuren.
DE3762615D1 (de) Verfahren zur herstellung von (2,2)-paracyclophan und dessen derivaten.
ATE66678T1 (de) Verfahren zur herstellung von makrolidderivaten.
DE69122936D1 (de) Verfahren zur Herstellung von Sialsäure
ATE145916T1 (de) Stereoselektives verfahren zur herstellung von beta-anomer angereicherten 2-deoxy-2,2-difluoro-d-ribofuranosyl-3,5-hydrox -geschützten 1-alkyl und aryl-sulfonat-zwischenprodukten
DE59008005D1 (de) Verfahren zur Herstellung von hochmolekularen Copolyarylensulfiden.
DE68914236D1 (de) Verfahren zur Herstellung von Natriumhyaluronat durch Gärung.
DE3576952D1 (de) Verfahren zur herstellung von 4-phenyl-pyrrol-derivaten.
ATE56430T1 (de) Verfahren zur herstellung von alkylthioalkansaeuresalzen.
DE3860105D1 (de) Verfahren zur herstellung von 4,4'-dichlordiphenylsulfonen.
DE3883911D1 (de) Verfahren zur Herstellung von Orotsäure durch Fermentierung.
ATE127470T1 (de) Verfahren zur herstellung von phosphatidylcholinderivaten.
DE69323352D1 (de) Verfahren zur Herstellung von mit Beta-Anomeren angereicherten 2-Deoxy-2,2-Difluor-D-Ribofuranosyl-Aryl-Sulfonaten
ATE15050T1 (de) Verfahren zur herstellung von cholesterinderivaten und zwischenprodukte dafuer.
DE69032153D1 (de) Verfahren zur Herstellung von Butantetracarboxylat
ATE104293T1 (de) Verfahren zur herstellung von thiophenderivaten.
DE59010027D1 (de) Verfahren zur diskontinuierlichen Herstellung von L-Carnitin auf mikrobiologischem Weg
ATE101849T1 (de) Verfahren zur herstellung von 4-chlor-3-alkoxybut-2e-en-s|urealkylester.
ATE43342T1 (de) Verfahren zur herstellung von hydrogeno- oder halogenosilanen.
ATE16696T1 (de) Verfahren zur herstellung von 3-alkyl-6-methylbeta-resorcylsaeureestern.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee